Literature DB >> 3859369

Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma.

T B Hakes, A N Daghestani, J B Dougherty, L Weiselberg, V Raymond.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3859369

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  3 in total

Review 1.  Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  L M Hollingshead; D Faulds
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

Review 2.  Anthracycline analogs: the past, present, and future.

Authors:  R B Weiss; G Sarosy; K Clagett-Carr; M Russo; B Leyland-Jones
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer.

Authors:  M D Green; J L Speyer; J C Wernz; N Colombo; U Beller; F M Muggia; E M Beckman
Journal:  Invest New Drugs       Date:  1990-08       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.